Compare DENTSPLY SIRONA Inc (XRAY) vs YieldMax Magnificent 7 Fund of Option Income ETFs (YMAG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DENTSPLY SIRONA Inc vs YieldMax Magnificent 7 Fund of Option Income ETFs — how do they compare? DENTSPLY SIRONA Inc trades at $10.68 (market cap $2.19B), while YieldMax Magnificent 7 Fund of Option Income ETFs trades at $11.2. The key difference: DENTSPLY SIRONA Inc pays a 5.04% dividend while YieldMax Magnificent 7 Fund of Option Income ETFs pays none, and DENTSPLY SIRONA Inc is trading nearer its 52-week high, YieldMax Magnificent 7 Fund of Option Income ETFs nearer its low. Which is the better fit depends on your goals.
| XRAY | YMAG | |
|---|---|---|
Market Cap | $2.19B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $14.68 | $15.98 |
52-Week Low | $9.64 | $10.76 |
Enterprise Value | $4.26B | — |
Dividend Yield | 5.04% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
XRAY trades at $10.99, down 3.43% on the day, reflecting ongoing challenges amid a bearish technical signal. The company reported a Q2 2026 earnings beat but faces declining revenue and negative profitability, with a net income margin of -14.99%. Cash flow trends show volatility, and the debt-to-asset ratio has worsened to 42.88% in 2025. Recent news highlights margin pressure and a class-action lawsuit inquiry, clouding the near-term outlook despite some institutional buying interest.
The investment outlook is cautious. While the stock trades below the consensus price target of $12.50, persistent net losses, high debt, and competitive pressures pose significant risks. Analyst sentiment is mixed with a 'Hold' consensus, suggesting limited upside until the company demonstrates sustained operational improvement and revenue stabilization.
YMAG trades at $11.26, down slightly (-0.18%) on the day. The technical outlook is bullish with moving averages supporting upward momentum, though oscillators remain neutral. The ETF maintains a consistent weekly dividend distribution strategy, with recent payouts ranging from $0.07 to $0.11 per share. Recent news highlights YieldMax's ongoing distribution announcements and trading activity, with the stock showing 2.7% gains in recent sessions according to Defense World (August 4, 2026).
The outlook remains positive given the bullish technical signals and consistent income generation through dividends. However, investors should monitor NAV stability during earnings periods as noted by Seeking Alpha (July 28, 2026). Key risks include option strategy execution and market volatility affecting the underlying Magnificent 7 components. The ETF's performance remains tied to successful option income generation and component stock stability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DENTSPLY SIRONA Inc
Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →About YieldMax Magnificent 7 Fund of Option Income ETFs
YMAG is an actively managed 'fund of funds' that provides equal-weighted exposure to the seven YieldMax ETFs tracking the 'Magnificent 7' tech giants (Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta, and Tesla). It seeks to generate high current income by harvesting option premiums across these leaders, offering a streamlined way to access concentrated tech volatility in an income-producing format.
Read more on YMAG →
